Superior myocardial preservation with HTK solution over Celsior in rat hearts with prolonged cold ischemia.
暂无分享,去创建一个
J. Luketich | D. Stolz | T. Billiar | A. Nakao | Sungsoo Lee | N. Shigemura | T. Kawamura | Chien-Sheng Huang | Y. Toyoda
[1] Paul Aurora,et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[2] B. Meiser,et al. Clinical heart transplantation with extended preservation time (>5 hours): experience with University of Wisconsin solution. , 2009, Transplantation proceedings.
[3] T. Minor,et al. Experimental small bowel preservation using Polysol: a new alternative to University of Wisconsin solution, Celsior and histidine-tryptophan-ketoglutarate solution? , 2007, World journal of gastroenterology.
[4] 박철희,et al. A Comparison of the Effects of Histidine-tryptophan-ketoglutarate Solution versus Cold Blood Cardioplegic Solution on Myocardial Protection in Mitral Valve Surgery , 2007 .
[5] M. Berry,et al. Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction. , 2006, Heart, lung & circulation.
[6] A. Choi,et al. Heart Allograft Protection with Low-Dose Carbon Monoxide Inhalation: Effects on Inflammatory Mediators and Alloreactive T-cell Responses , 2006, Transplantation.
[7] Y. Chuang,et al. Successful heart transplantation after 13 hours of donor heart ischemia with the use of HTK solution: a case report. , 2005, Transplantation proceedings.
[8] M. Garlicki. May preservation solution affect the incidence of graft vasculopathy in transplanted heart? , 2003, Annals of transplantation.
[9] G. Tenderich,et al. Creatine kinase and troponin after myocardial preservation using HTK solution (Custoidol) for clinical heart transplantation. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[10] B. Meiser,et al. The New German Allocation System for Donated Thoracic Organs Causes Longer Ischemia and Increased Costs , 2002, The Thoracic and cardiovascular surgeon.
[11] S. Baicu,et al. Acid-base buffering in organ preservation solutions as a function of temperature: new parameters for comparing buffer capacity and efficiency. , 2002, Cryobiology.
[12] M. Gebhard,et al. Celsior Versus Custodiol: Early Postischemic Recovery After Cardioplegia and Ischemia at 5°C , 2002 .
[13] J. Hohlfeld,et al. Pulmonary preservation with Bretscheider's HTK and Celsior solution in minipigs. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[14] J. Stone,et al. Analysis of robust innate immune response after transplantation in the absence of adaptive immunity1 , 2002, Transplantation.
[15] D. Salazar,et al. Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients. , 2001, Archives of medical research.
[16] N. Kneteman,et al. Conservation of phosphorylation state of cardiac phosphofructokinase during in vitro hypothermic hypoxia. , 2000, American Journal of Physiology. Heart and Circulatory Physiology.
[17] P. Narayan,et al. Heart preservation for transplantation: principles and strategies. , 1999, The Annals of thoracic surgery.
[18] J. Drukała,et al. Myocardial protection for transplantation. , 1999, Transplantation proceedings.
[19] G. Laufer,et al. Improved graft function using a new myocardial preservation solution: Celsior. Preliminary data from a randomized prospective study. , 1999, Transplantation proceedings.
[20] A. Haverich,et al. Celsior solution for improvement of currently used clinical standards of lung preservation in an ex vivo rat model. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[21] M. Oz,et al. Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. , 1994, The Journal of clinical investigation.
[22] R. Montalti,et al. Preliminary results of a clinical randomized study comparing Celsior and HTK solutions in liver preservation for transplantation. , 2005, Transplantation proceedings.
[23] P. Menasché,et al. Experimental evaluation of Celsior, a new heart preservation solution. , 1994, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[24] R. Hetzer,et al. Myocardial preservation using HTK solution for heart transplantation. A multicenter study. , 1993, European Journal of Cardio-Thoracic Surgery.